<DOC>
	<DOCNO>NCT00943891</DOCNO>
	<brief_summary>1 . To determine association LVD clinico-pathologic variable archive colorectal cancer Nasopharyngeal carcinoma specimens 2 . To determine association VEGF-C , -D expression COX-2 expression clinico-pathologic variable colorectal cancer Nasopharyngeal carcinoma 3 . To determine effect celecoxib lymphangiogenesis Nasopharyngeal carcinoma Lymphangiogenesis factor modulate lymphangiogenesis associate clinico-pathological outcome Nasopharyngeal carcinoma colorectal cancer . Celecoxib down-regulates lymphangiogenesis Archival colorectal cancer Nasopharyngeal carcinoma tumor specimen obtain Department Pathology . To determine effect celecoxib lymphangiogenesis Nasopharyngeal carcinoma , investigator intend analyze archive specimen collect previously conduct study . Colorectal tumor nodal specimens Nasopharyngeal carcinoma primary examine MVD , LVD growth factor expression use establish haematoxylin eosin immunohistochemical technique . Quantification LVD MVD shall perform two pathologist blind clinico-pathological variable use standardised method .</brief_summary>
	<brief_title>A Study Lymphangiogenesis Colorectal Nasopharyngeal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>Male female patient eligible Patients 21 year old</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>